Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews · Gynaecology and Fertility

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 1 · 33.3%Very low 2 · 66.7%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Dopamine agonist vs other active intervention

Any other adverse events · women undergoing assisted reproduction

1 finding from 1 review

Dopamine agonists for preventing ovarian hyperstimulation syndrome 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 170 participants
GRADE not reported

Dopamine agonist vs placebo or no intervention

Any other adverse events · women undergoing assisted reproduction

It is very uncertain whether dopamine agonist changes any other adverse events compared with placebo/no intervention (very low certainty).

1 finding from 1 review

Dopamine agonists for preventing ovarian hyperstimulation syndrome 2021 · Cochrane Headline outcomes only
OR 4.54 [1.49, 13.84]
2 studies · 264 participants
Very low

Dopamine agonist plus co‐intervention vs co‐intervention

Any other adverse events · women undergoing assisted reproduction

It is very uncertain whether dopamine agonist plus co‐intervention changes any other adverse events compared with co‐intervention (very low certainty).

1 finding from 1 review

Dopamine agonists for preventing ovarian hyperstimulation syndrome 2021 · Cochrane Headline outcomes only
OR 3.03 [0.12, 75.28]
2 studies · 366 participants
Very low